Forum Finance Group’s Bristol-Myers Squibb BMY Stock Holding History

Forum Finance Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10K	Hold	210	–	–	﹤0.01%	294
2026 Q1	$10K	Buy	+210	New	+$12.2K	0.01%	273

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Forum Finance Group's BMY Position: Q2 2026 in Review

Forum Finance Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 210 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #294.

Forum Finance Group first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Forum Finance Group held 210 shares of Bristol-Myers Squibb worth $10K as of Q2 2026.
Forum Finance Group left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up ﹤0.01% of Forum Finance Group's portfolio in Q2 2026, its #294 holding.
Forum Finance Group first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Forum Finance Group's 13F filing for Q2 2026, filed 14 Aug 2026.